Weekly Digest – September 2025 Weekly Digest – September 2025 02 September 2025: Avenzo Therapeutics announces FDA clearance of Investigational New Drug application for AVZO-103, a potential best-in-class Nectin4/TROP2 bispecific antibody-drug conjugate Avenzo Therapeutics received FDA clearance of its IND […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id